The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abeona Therapeutics Inc. | COM | 00289Y107 | 34,950 | 2,184,364 | SH | SOLE | 2,184,364 | 0 | 0 | ||
ACADIA Pharmaceuticals Inc. | COM | 004225108 | 415,777 | 27,228,338 | SH | SOLE | 27,228,338 | 0 | 0 | ||
Acceleron Pharma Inc. | COM | 00434H108 | 7,952 | 163,900 | SH | SOLE | 163,900 | 0 | 0 | ||
Achillion Pharmaceuticals, Inc. | COM | 00448Q201 | 5,500 | 1,943,620 | SH | SOLE | 1,943,620 | 0 | 0 | ||
Acorda Therapeutics, Inc. | COM | 00484M106 | 4,968 | 173,100 | SH | SOLE | 173,100 | 0 | 0 | ||
Adamas Pharmaceuticals, Inc. | COM | 00548A106 | 4,459 | 172,630 | SH | SOLE | 172,630 | 0 | 0 | ||
Adaptimmune Therapeutics plc | SPONSORED ADR | 00653A107 | 1,187 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Aeglea BioTherapeutics, Inc. | COM | 00773J103 | 14,684 | 1,387,872 | SH | SOLE | 1,387,872 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 4,063 | 60,155 | SH | SOLE | 60,155 | 0 | 0 | ||
Aevi Genomic Medicine, Inc. | COM | 00835P105 | 4,501 | 4,055,142 | SH | SOLE | 4,055,142 | 0 | 0 | ||
Affimed N.V. | COM | N01045108 | 660 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 18,121 | 673,908 | SH | SOLE | 673,908 | 0 | 0 | ||
Akari Therapeutics, Plc | SPONSORED ADR | 00972G108 | 115 | 58,770 | SH | SOLE | 58,770 | 0 | 0 | ||
Albireo Pharma, Inc. | COM | 01345P106 | 8,875 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Alexion Pharmaceuticals, Inc. | COM | 015351109 | 1,062,214 | 8,555,894 | SH | SOLE | 8,555,894 | 0 | 0 | ||
Alkermes plc | SHS | G01767105 | 4,126 | 100,251 | SH | SOLE | 100,251 | 0 | 0 | ||
Amarin Corporation plc | SPONSORED ADR NEW | 023111206 | 70,049 | 22,669,509 | SH | SOLE | 22,669,509 | 0 | 0 | ||
AnaptysBio, Inc. | COM | 032724106 | 5,192 | 73,086 | SH | SOLE | 73,086 | 0 | 0 | ||
Apellis Pharmaceuticals, Inc. | COM | 03753U106 | 4,314 | 196,078 | SH | SOLE | 196,078 | 0 | 0 | ||
Aquinox Pharmaceuticals, Inc. | COM | 03842B101 | 28,976 | 10,934,154 | SH | SOLE | 10,934,154 | 0 | 0 | ||
Arbutus Biopharma Corporation | COM | 03879J100 | 1,318 | 180,582 | SH | SOLE | 180,582 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 1,488 | 121,534 | SH | SOLE | 121,534 | 0 | 0 | ||
argenx SE | SPONSORED ADR | 04016X101 | 79,691 | 961,754 | SH | SOLE | 961,754 | 0 | 0 | ||
Array BioPharma Inc. | COM | 04269X105 | 94,911 | 5,656,196 | SH | SOLE | 5,656,196 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 188,741 | 2,837,352 | SH | SOLE | 2,837,352 | 0 | 0 | ||
Assembly Biosciences, Inc. | COM | 045396108 | 5,826 | 148,587 | SH | SOLE | 148,587 | 0 | 0 | ||
Audentes Therapeutics, Inc. | COM | 05070R104 | 15,025 | 393,222 | SH | SOLE | 393,222 | 0 | 0 | ||
Autolus Therapeutics plc | SPON ADS | 05280R100 | 6,304 | 235,294 | SH | SOLE | 235,294 | 0 | 0 | ||
BeiGene, Ltd. | SPONSORED ADR | 07725L102 | 1,838,584 | 11,959,824 | SH | SOLE | 11,959,824 | 0 | 0 | ||
Bellicum Pharmaceuticals, Inc. | COM | 079481107 | 30,210 | 4,093,447 | SH | SOLE | 4,093,447 | 0 | 0 | ||
BioCryst Pharmaceuticals, Inc. | COM | 09058V103 | 80,290 | 14,012,172 | SH | SOLE | 14,012,172 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | COM | 09060J106 | 620 | 210,021 | SH | SOLE | 210,021 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | COM | 09061G101 | 714,327 | 7,583,084 | SH | SOLE | 7,583,084 | 0 | 0 | ||
BioTime, Inc. | *W EXP 10/1/201 | 09066L162 | 1 | 20,084 | SH | SOLE | 20,084 | 0 | 0 | ||
bluebird bio, Inc. | COM | 09609G100 | 31,390 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
Catalyst Pharmaceuticals, Inc. | COM | 14888U101 | 11,301 | 3,621,962 | SH | SOLE | 3,621,962 | 0 | 0 | ||
Cellectis S.A. | SPONSORED ADS | 15117K103 | 1,415 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
Cerus Corporation | COM | 157085101 | 71,702 | 10,749,937 | SH | SOLE | 10,749,937 | 0 | 0 | ||
ChemoCentryx, Inc. | COM | 16383L106 | 5,453 | 414,029 | SH | SOLE | 414,029 | 0 | 0 | ||
Clementia Pharmaceuticals Inc. | COM | 185575107 | 15,695 | 1,192,595 | SH | SOLE | 1,192,595 | 0 | 0 | ||
ContraFect Corporation | COM | 212326102 | 15,808 | 7,153,076 | SH | SOLE | 7,153,076 | 0 | 0 | ||
Corbus Pharmaceuticals Holdings, Inc. | COM | 21833P103 | 1,250 | 247,450 | SH | SOLE | 247,450 | 0 | 0 | ||
Cyclacel Pharmaceuticals, Inc. | PFD CONV EX 6% | 23254L207 | 89 | 13,253 | SH | SOLE | 13,253 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 65,996 | 4,917,700 | SH | SOLE | 4,917,700 | 0 | 0 | ||
DBV Technologies S.A. | SPONSORED ADR | 23306J101 | 106,279 | 5,509,560 | SH | SOLE | 5,509,560 | 0 | 0 | ||
Dynavax Technologies Corporation | COM NEW | 268158201 | 1,144 | 75,000 | SH | SOLE | 75,000 | 0 | 0 | ||
Endocyte, Inc. | COM | 29269A102 | 31,434 | 2,277,799 | SH | SOLE | 2,277,799 | 0 | 0 | ||
ERYTECH Pharma S.A. | SPONSORED ADR | 29604W108 | 34,470 | 3,085,969 | SH | SOLE | 3,085,969 | 0 | 0 | ||
Exelixis, Inc. | COM | 30161Q104 | 11,049 | 513,410 | SH | SOLE | 513,410 | 0 | 0 | ||
Foamix Pharmaceuticals Ltd. | SHS | M46135105 | 7,466 | 1,490,201 | SH | SOLE | 1,490,201 | 0 | 0 | ||
Forty Seven, Inc. | COM | 34983P104 | 4,000 | 250,000 | SH | SOLE | 250,000 | 0 | 0 | ||
Fulgent Genetics, Inc. | COM | 359664109 | 518 | 125,000 | SH | SOLE | 125,000 | 0 | 0 | ||
G1 Therapeutics, Inc. | COM | 3621LQ109 | 7,366 | 169,492 | SH | SOLE | 169,492 | 0 | 0 | ||
Galapagos NV | SPONSORED ADR | 36315X101 | 23,957 | 259,894 | SH | SOLE | 259,894 | 0 | 0 | ||
Galmed Pharmaceuticals Ltd. | SHS | M47238106 | 7,570 | 636,140 | SH | SOLE | 636,140 | 0 | 0 | ||
Genomic Health, Inc. | COM | 37244C101 | 695,045 | 13,790,574 | SH | SOLE | 13,790,574 | 0 | 0 | ||
GlycoMimetics, Inc. | COM | 38000Q102 | 4,697 | 291,214 | SH | SOLE | 291,214 | 0 | 0 | ||
GW Pharmaceuticals plc | ADS | 36197T103 | 44,904 | 321,800 | SH | SOLE | 321,800 | 0 | 0 | ||
Halozyme Therapeutics, Inc. | COM | 40637H109 | 21,660 | 1,283,929 | SH | SOLE | 1,283,929 | 0 | 0 | ||
Heron Therapeutics, Inc. | COM | 427746102 | 195,233 | 5,025,298 | SH | SOLE | 5,025,298 | 0 | 0 | ||
Idera Pharmaceuticals, Inc. | COM NEW | 45168K405 | 51,024 | 38,654,811 | SH | SOLE | 38,654,811 | 0 | 0 | ||
Incyte Corporation | COM | 45337C102 | 2,294,819 | 34,251,034 | SH | SOLE | 34,251,034 | 0 | 0 | ||
Infinity Pharmaceuticals, Inc. | COM | 45665G303 | 1,109 | 580,400 | SH | SOLE | 580,400 | 0 | 0 | ||
InflaRx N.V. | COM | N44821101 | 8,347 | 258,824 | SH | SOLE | 258,824 | 0 | 0 | ||
Insmed Incorporated | COM PAR $.01 | 457669307 | 16,555 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Intellia Therapeutics, Inc. | COM | 45826J105 | 14,964 | 546,922 | SH | SOLE | 546,922 | 0 | 0 | ||
Invitae Corporation | COM | 46185L103 | 61,736 | 8,399,411 | SH | SOLE | 8,399,411 | 0 | 0 | ||
Jounce Therapeutics, Inc. | COM | 481116101 | 766 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Kiniksa Pharmaceuticals, Ltd. | COM CL A | G5269C101 | 52,050 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
Krystal Biotech, Inc. | COM | 501147102 | 2,974 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
La Jolla Pharmaceutical Company | COM PAR $.0001 2 | 503459604 | 4,512 | 154,675 | SH | SOLE | 154,675 | 0 | 0 | ||
MacroGenics, Inc. | COM | 556099109 | 4,495 | 217,695 | SH | SOLE | 217,695 | 0 | 0 | ||
Madrigal Pharmaceuticals, Inc. | COM | 558868105 | 327,035 | 1,169,278 | SH | SOLE | 1,169,278 | 0 | 0 | ||
MediWound Ltd. | ORD SHS | M68830104 | 1,559 | 226,000 | SH | SOLE | 226,000 | 0 | 0 | ||
Menlo Therapeutics Inc. | COM | 586858102 | 5,684 | 700,000 | SH | SOLE | 700,000 | 0 | 0 | ||
Merus N.V. | COM | N5749R100 | 26,402 | 1,160,014 | SH | SOLE | 1,160,014 | 0 | 0 | ||
Mirati Therapeutics, Inc. | COM | 60468T105 | 123,914 | 2,513,462 | SH | SOLE | 2,513,462 | 0 | 0 | ||
Molecular Templates, Inc. | COM | 608550109 | 379 | 72,412 | SH | SOLE | 72,412 | 0 | 0 | ||
Momenta Pharmaceuticals, Inc. | COM | 60877T100 | 6,309 | 308,500 | SH | SOLE | 308,500 | 0 | 0 | ||
MyoKardia, Inc. | COM | 62857M105 | 21,504 | 433,121 | SH | SOLE | 433,121 | 0 | 0 | ||
Nabriva Therapeutics plc | SHS | G63637105 | 3,265 | 938,235 | SH | SOLE | 938,235 | 0 | 0 | ||
Natera, Inc. | COM | 632307104 | 4,304 | 228,676 | SH | SOLE | 228,676 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | COM | 64125C109 | 92,800 | 944,624 | SH | SOLE | 944,624 | 0 | 0 | ||
NewLink Genetics Corporation | COM | 651511107 | 2,415 | 507,273 | SH | SOLE | 507,273 | 0 | 0 | ||
Ovid Therapeutics Inc. | COM | 690469101 | 1,932 | 247,733 | SH | SOLE | 247,733 | 0 | 0 | ||
Progenics Pharmaceuticals, Inc. | COM | 743187106 | 7,871 | 979,016 | SH | SOLE | 979,016 | 0 | 0 | ||
Proteon Therapeutics, Inc. | COM | 74371L109 | 732 | 298,591 | SH | SOLE | 298,591 | 0 | 0 | ||
Ra Pharmaceuticals, Inc. | COM | 74933V108 | 1,771 | 177,952 | SH | SOLE | 177,952 | 0 | 0 | ||
Rhythm Pharmaceuticals, Inc. | COM | 76243J105 | 84,658 | 2,708,200 | SH | SOLE | 2,708,200 | 0 | 0 | ||
Rigel Pharmaceuticals, Inc. | COM NEW | 766559603 | 2,948 | 1,041,612 | SH | SOLE | 1,041,612 | 0 | 0 | ||
Ritter Pharmaceuticals, Inc. | COM NEW | 767836307 | 720 | 279,999 | SH | SOLE | 279,999 | 0 | 0 | ||
Sage Therapeutics, Inc. | COM | 78667J108 | 96,000 | 613,300 | SH | SOLE | 613,300 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 18,232 | 1,283,923 | SH | SOLE | 1,283,923 | 0 | 0 | ||
Seattle Genetics, Inc. | COM | 812578102 | 3,388,948 | 51,046,060 | SH | SOLE | 51,046,060 | 0 | 0 | ||
Selecta Biosciences, Inc. | COM | 816212104 | 1,242 | 93,750 | SH | SOLE | 93,750 | 0 | 0 | ||
Sesen Bio, Inc. | COM | 817763105 | 5,118 | 2,624,412 | SH | SOLE | 2,624,412 | 0 | 0 | ||
Solid Biosciences Inc. | COM | 83422E105 | 20,946 | 587,884 | SH | SOLE | 587,884 | 0 | 0 | ||
Spark Therapeutics, Inc. | COM | 84652J103 | 114,551 | 1,384,130 | SH | SOLE | 1,384,130 | 0 | 0 | ||
Spring Bank Pharmaceuticals, Inc. | COM | 849431101 | 4,422 | 373,144 | SH | SOLE | 373,144 | 0 | 0 | ||
Stemline Therapeutics, Inc. | COM | 85858C107 | 715 | 44,524 | SH | SOLE | 44,524 | 0 | 0 | ||
Sunesis Pharmaceuticals, Inc. | COM PAR | 867328700 | 1,180 | 556,665 | SH | SOLE | 556,665 | 0 | 0 | ||
Syros Pharmaceuticals, Inc. | COM | 87184Q107 | 5,869 | 574,835 | SH | SOLE | 574,835 | 0 | 0 | ||
T2 Biosystems, Inc. | COM | 89853L104 | 774 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Tetraphase Pharmaceuticals, Inc. | COM | 88165N105 | 3,338 | 935,000 | SH | SOLE | 935,000 | 0 | 0 | ||
Tonix Pharmaceuticals Holdings Corp. | COM | 890260409 | 3,113 | 699,500 | SH | SOLE | 699,500 | 0 | 0 | ||
Trevena, Inc. | COM | 89532E109 | 1,368 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
Tricida, Inc. | COM | 89610F101 | 47,840 | 1,600,000 | SH | SOLE | 1,600,000 | 0 | 0 | ||
Trillium Therapeutics Inc. | COM NEW | 89620X506 | 3,071 | 511,763 | SH | SOLE | 511,763 | 0 | 0 | ||
uniQure N.V. | SHS | N90064101 | 22,869 | 605,000 | SH | SOLE | 605,000 | 0 | 0 | ||
Vanda Pharmaceuticals Inc. | COM | 921659108 | 5,912 | 310,354 | SH | SOLE | 310,354 | 0 | 0 | ||
Versartis, Inc. | COM | 92529L102 | 4,913 | 2,426,310 | SH | SOLE | 2,426,310 | 0 | 0 | ||
Xencor, Inc. | COM | 98401F105 | 32,275 | 872,072 | SH | SOLE | 872,072 | 0 | 0 | ||
Zymeworks Inc. | COM | 98985W102 | 19,378 | 1,311,085 | SH | SOLE | 1,311,085 | 0 | 0 | ||
Aegerion Pharmaceuticals, Inc. | NOTE 2% 8/15/2019 | 00767EAB8 | 6,027 | 9,517,000 | PRN | SOLE | 9,517,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.75% 10/15/2018 | 09061GAE1 | 13,000 | 12,228,000 | PRN | SOLE | 12,228,000 | 0 | 0 | ||
BioMarin Pharmaceutical Inc. | NOTE 0.599% 8/1/2024 | 09061GAH4 | 15,198 | 15,000,000 | PRN | SOLE | 15,000,000 | 0 | 0 | ||
Corsicanto II Designated Activity Company | NOTE 3.5% 1/5/2047 | 220485AB2 | 10,908 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
Neurocrine Biosciences, Inc. | NOTE 2.25% 5/15/2024 | 64125CAD1 | 14,466 | 10,000,000 | PRN | SOLE | 10,000,000 | 0 | 0 | ||
Novavax, Inc. | NOTE 3.75% 2/1/23 | 670002AB0 | 42,667 | 73,500,000 | PRN | SOLE | 73,500,000 | 0 | 0 |